April 4, 2026
Headlines

Hyro Raises $45 M to Cement AI Agents as the New Frontline in Healthcare Access

Editor05 mins

Hyro, a conversational‑AI platform built for healthcare enterprises, has announced a $45 million strategic growth funding round led by Healthier Capital, with participation from Norwest, Define Ventures, and strategic investors including Bon Secours Mercy Health and ServiceNow Ventures. The financing comes just ten months after Hyro’s previous raise and brings its total funding to approximately $95 million. Co‑founded by…

Read More

Best Day Brewing Secures $22.5 Million in 2024 Funding to Expand Non-Alcoholic Beer Offerings

Editor06 mins

Best Day Brewing, recognized as the fastest-growing non-alcoholic craft beer brand in the United States, has successfully raised a total of $22.5 million in funding this year. This impressive backing from both new and existing investors highlights the burgeoning confidence in the non-alcoholic beverage sector, positioning Best Day Brewing firmly as the leading contender in…

Read More
ZAST.AI

The Zero-False-Positive Era: ZAST.AI Secures $6M Pre-A Lead by Hillhouse Capital

Editor05 mins

In a move that promises to dismantle the most persistent barrier in cybersecurity—the plague of actionable alert fatigue—ZAST.AI has successfully closed a $6 million Pre-A funding round. The investment, led by the premier global investment firm Hillhouse Capital, brings the startup’s total capital to nearly $10 million, signaling a robust market appetite for verified vulnerability…

Read More

ThinkCyte Secures $32 Million in Series C Funding to Expand Global Reach of VisionSort™, Revolutionary AI-Driven Cell Sorting Technology

Editor05 mins

ThinkCyte Inc., a trailblazer in innovative cell analysis technology, has announced a significant milestone in its growth journey. The company has successfully closed a Series C funding round, raising $32 million in total, which includes an extension round of $15 million. This impressive funding round was spearheaded by the Japan Green Investment Corp. for Carbon…

Read More

Gloo Secures $110 Million to Revolutionize Faith-Based Technology and AI Integration

Editor03 mins

Gloo, the prominent technology platform designed to unite the faith community, has successfully completed a substantial $110 million funding round. This investment is set to enhance the development of Gloo’s platform and its focus on integrating advanced AI capabilities, while also launching Gloo Ventures to expand its influence and impact within the faith ecosystem. Gloo’s…

Read More

Nebul Secures €20M Investment to Expand Sovereign-Hybrid Cloud Solutions Across Europe

Editor04 mins

Nebul, a pioneering force in sovereign-hybrid cloud solutions based in Amsterdam, has announced a significant milestone in its journey with a €20M investment from BeStacking. This funding round, spearheaded by seasoned founders dedicated to fostering transformative IT ventures across Europe, marks a pivotal moment for Nebul’s expansion strategy. Founded in 2022 under the leadership of…

Read More

Excellergy Raises $70M to Rewrite the Allergy Playbook with Trifunctional Biologics

Editor06 mins

A new force has entered the allergy‑therapeutics arena. Excellergy has announced a bold $70 million Series A round designed to advance its lead candidates—“trifunctional” Effector Cell Response Inhibitors (ECRIs)—toward clinical proof. The molecules aim to simultaneously strip IgE from bound immune cells, neutralize free IgE, and tamp down the receptor expression that fuels allergic cascades….

Read More

Bio-Logical Secures $1.3M to Expand Biochar Operations, Boost Climate Resilience for Kenyan Farmers

Editor05 mins

Bio-Logical, a pioneering climate tech firm specializing in biochar carbon removal, has successfully raised $1.3 million in funding to amplify its efforts in combating climate change and enhancing the resilience of Kenyan smallholder farmers. This investment marks a significant milestone for the company as it gears up to expand its Mt. Kenya biochar facility, aiming…

Read More

RevOpsis Therapeutics Secures $1.8M NEI SBIR Grant to Propel Innovative Ophthalmic Therapies

Editor05 mins

In a significant advancement for ophthalmic medicine, RevOpsis Therapeutics, a pioneering biopharmaceutical firm, has been awarded a Small Business Innovation Research (SBIR) grant exceeding $1.8 million from the National Eye Institute (NEI), part of the National Institutes of Health (NIH). This funding will bolster the development of their lead asset, RO-104, aimed at treating neovascular…

Read More